Carmell Therapeutics Corporation (CTCX) — Financial Flexibility Index
Carmell Therapeutics Corporation (CTCX) has a Financial Flexibility Index of -0.11x as of March 2025. Free cash flow of $-752.95K (operating CF $-752.95K minus capex $0.00) represents 0% of total liabilities ($7.14 Million). Also explore how fast is Carmell Therapeutics Corporation growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Carmell Therapeutics Corporation Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for Carmell Therapeutics Corporation across 4 annual periods. See CTCX equity financing ratio to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for Carmell Therapeutics Corporation (2021–2024)
Year-by-year free cash flow to debt coverage for Carmell Therapeutics Corporation. For the full company profile including market capitalisation, see Carmell Therapeutics Corporation stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.71x | $-4.39 Million | $-4.39 Million | $6.19 Million | ▼ -234.3% |
| 2023 | -0.21x | $-8.32 Million | $-8.35 Million | $39.20 Million | ▼ -145.2% |
| 2022 | -0.09x | $-3.42 Million | $-3.43 Million | $39.54 Million | ▼ -130.4% |
| 2021 | -0.04x | $-1.17 Million | $-1.18 Million | $31.13 Million | — |